Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Impact of the supplementation of kidney mass on blood pressure and progression of kidney disease.

Ots M, Troy JL, Rennke HG, Mackenzie HS, Brenner BM.

Nephrol Dial Transplant. 2004 Feb;19(2):337-41.

PMID:
14736956
2.

Recipient hypertension potentiates chronic functional and structural injury of rat renal allografts.

Kusaka M, Mackenzie HS, Ziai F, Hancock WW, Tilney NL.

Transplantation. 2002 Aug 15;74(3):307-14.

PMID:
12177607
3.

High glucose-altered gene expression in mesangial cells. Actin-regulatory protein gene expression is triggered by oxidative stress and cytoskeletal disassembly.

Clarkson MR, Murphy M, Gupta S, Lambe T, Mackenzie HS, Godson C, Martin F, Brady HR.

J Biol Chem. 2002 Mar 22;277(12):9707-12. Epub 2002 Jan 9. Erratum in: J Biol Chem 2002 Jun 21;277(25):23100-2.

4.

Adrenomedullin and its receptor complexes in remnant kidneys of rats with renal mass ablation: decreased expression of calcitonin receptor-like receptor and receptor-activity modifying protein-3.

Totsune K, Takahashi K, Mackenzie HS, Arihara Z, Satoh F, Sone M, Murakami O, Ito S, Brenner BM, Mouri T.

Peptides. 2001 Nov;22(11):1933-7.

PMID:
11754984
5.

Early and late inflammatory changes occurring in rat renal isografts from brain dead donors.

Kusaka M, Pratschke J, Wilhelm MJ, Ziai F, Zandi-Nejad K, Mackenzie HS, Hancock WW, Tilney NL.

Transplant Proc. 2001 Feb-Mar;33(1-2):867-8. No abstract available.

PMID:
11267108
6.

Donor hypertension and recipient immune responsiveness in chronic rat cardiac allograft rejection.

Wilhelm MJ, Pratschke J, Paz DM, Laskowski IA, Mackenzie HS, Hancock WW, Tilney NL.

Transplant Proc. 2001 Feb-Mar;33(1-2):321-2. No abstract available.

PMID:
11266841
7.

Mechanisms underlying renoprotection during renin-angiotensin system blockade.

Taal MW, Chertow GM, Rennke HG, Gurnani A, Jiang T, Shahsafaei A, Troy JL, Brenner BM, Mackenzie HS.

Am J Physiol Renal Physiol. 2001 Feb;280(2):F343-55.

8.
9.

Proinflammatory gene expression and macrophage recruitment in the rat remnant kidney.

Taal MW, Zandi-Nejad K, Weening B, Shahsafaei A, Kato S, Lee KW, Ziai F, Jiang T, Brenner BM, MacKenzie HS.

Kidney Int. 2000 Oct;58(4):1664-76.

10.

Cellular and molecular mediators in common pathway mechanisms of chronic renal disease progression.

Taal MW, Omer SA, Nadim MK, Mackenzie HS.

Curr Opin Nephrol Hypertens. 2000 Jul;9(4):323-31. Review.

PMID:
10926167
11.

Renal allograft protection with losartan in Fisher-->Lewis rats: hemodynamics, macrophages, and cytokines.

Ziai F, Nagano H, Kusaka M, Coito AJ, Troy JL, Nadeau KC, Rennke HG, Tilney NL, Brenner BM, MacKenzie HS.

Kidney Int. 2000 Jun;57(6):2618-25.

12.

Long-term regulation of urea transporter expression by vasopressin in Brattleboro rats.

Shayakul C, Smith CP, Mackenzie HS, Lee WS, Brown D, Hediger MA.

Am J Physiol Renal Physiol. 2000 Apr;278(4):F620-7.

13.
14.

Activation of inflammatory mediators in rat renal isografts by donor brain death.

Kusaka M, Pratschke J, Wilhelm MJ, Ziai F, Zandi-Nejad K, Mackenzie HS, Hancock WW, Tilney NL.

Transplantation. 2000 Feb 15;69(3):405-10.

PMID:
10706051
15.

Renin-angiotensin blockade lowers MCP-1 expression in diabetic rats.

Kato S, Luyckx VA, Ots M, Lee KW, Ziai F, Troy JL, Brenner BM, MacKenzie HS.

Kidney Int. 1999 Sep;56(3):1037-48.

16.

Angiotensin receptor blockers in chronic renal disease: the promise of a bright clinical future.

Mackenzie HS, Ziai F, Omer SA, Nadim MK, Taal MW.

J Am Soc Nephrol. 1999 Apr;10 Suppl 12:S283-6. Review.

PMID:
10201884
17.

Systemic hypertension accelerates chronic rejection of renal allografts in the rat.

Kusaka M, Ziai F, Hancock WW, Tilney NL, Mackenzie HS.

Transplant Proc. 1999 Feb-Mar;31(1-2):869. No abstract available.

PMID:
10083379
18.

Renal function in high-output heart failure in rats: role of endogenous natriuretic peptides.

Willenbrock R, Pagel I, Scheuermann M, Höhnel K, Mackenzie HS, Brenner BM, Dietz R.

J Am Soc Nephrol. 1999 Mar;10(3):572-80.

19.
20.

Upregulation of atrial natriuretic peptide gene expression in remnant kidney of rats with reduced renal mass.

Totsune K, Mackenzie HS, Totsune H, Troy JL, Lytton J, Brenner BM.

J Am Soc Nephrol. 1998 Sep;9(9):1613-9.

21.

Effects of explosive brain death on cytokine activation of peripheral organs in the rat.

Takada M, Nadeau KC, Hancock WW, Mackenzie HS, Shaw GD, Waaga AM, Chandraker A, Sayegh MH, Tilney NL.

Transplantation. 1998 Jun 27;65(12):1533-42.

PMID:
9665067
22.
23.

Candesartan cilexetil reduces chronic renal allograft injury in Fisher-->Lewis rats.

Mackenzie HS, Ziai F, Nagano H, Azuma H, Troy JL, Rennke HG, Tilney NL, Brenner BM.

J Hypertens Suppl. 1997 Dec;15(6):S21-5.

PMID:
9493123
25.

Current strategies for retarding progression of renal disease.

Mackenzie HS, Brenner BM.

Am J Kidney Dis. 1998 Jan;31(1):161-70. Review.

PMID:
9428469
26.

Angiotensin receptor antagonists in experimental models of chronic renal failure.

Mackenzie HS, Ots M, Ziai F, Lee KW, Kato S, Brenner BM.

Kidney Int Suppl. 1997 Dec;63:S140-3. Review.

PMID:
9407443
27.

Nephron mass as a risk factor for progression of renal disease.

Brenner BM, Mackenzie HS.

Kidney Int Suppl. 1997 Dec;63:S124-7. Review.

PMID:
9407439
28.

Antigen-independent determinants of graft survival in living-related kidney transplantation.

Chertow GM, Brenner BM, Mori M, MacKenzie HS, Milford EL.

Kidney Int Suppl. 1997 Dec;63:S84-6.

PMID:
9407430
29.

Cellular and molecular predictors of chronic renal dysfunction after initial ischemia/reperfusion injury of a single kidney.

Azuma H, Nadeau K, Takada M, Mackenzie HS, Tilney NL.

Transplantation. 1997 Jul 27;64(2):190-7.

PMID:
9256172
30.

Nephron mass modulates the hemodynamic, cellular, and molecular response of the rat renal allograft.

Azuma H, Nadeau K, Mackenzie HS, Brenner BM, Tilney NL.

Transplantation. 1997 Feb 27;63(4):519-28.

PMID:
9047144
31.

Antigen-independent determinants of cadaveric kidney transplant failure.

Chertow GM, Milford EL, Mackenzie HS, Brenner BM.

JAMA. 1996 Dec 4;276(21):1732-6.

PMID:
8940321
32.

The angiotensin receptor antagonist, irbesartan, reduces renal injury in experimental chronic renal failure.

Ziai F, Ots M, Provoost AP, Troy JL, Rennke HG, Brenner BM, Mackenzie HS.

Kidney Int Suppl. 1996 Dec;57:S132-6.

PMID:
8941934
33.

Antigen-independent determinants of late renal allograft outcome: the role of renal mass.

Mackenzie HS, Brenner BM.

Curr Opin Nephrol Hypertens. 1996 Jul;5(4):289-96. Review. No abstract available.

PMID:
8823524
34.

Congenital oligonephropathy: The fetal flaw in essential hypertension?

Mackenzie HS, Lawler EV, Brenner BM.

Kidney Int Suppl. 1996 Jun;55:S30-4. Review.

PMID:
8743507
35.

The hyperfiltration theory: a paradigm shift in nephrology.

Brenner BM, Lawler EV, Mackenzie HS.

Kidney Int. 1996 Jun;49(6):1774-7. Review.

36.

Augmenting kidney mass at transplantation abrogates chronic renal allograft injury in rats.

Mackenzie HS, Azuma H, Troy JL, Rennke HG, Tilney NL, Brenner BM.

Proc Assoc Am Physicians. 1996 Mar;108(2):127-33.

PMID:
8705732
37.

Non-immunologic predictors of chronic renal allograft failure: data from the United Network of Organ Sharing.

Chertow GM, Brenner BM, Mackenzie HS, Milford EL.

Kidney Int Suppl. 1995 Dec;52:S48-51.

PMID:
8587283
38.

Renal mass as a determinant of late allograft outcome: insights from experimental studies in rats.

Mackenzie HS, Azuma H, Rennke HG, Tilney NL, Brenner BM.

Kidney Int Suppl. 1995 Dec;52:S38-42.

PMID:
8587281
39.

Renal effects of high-dose natriuretic peptide receptor blockade in rats with congestive heart failure.

Zhang PL, Mackenzie HS, Totsune K, Troy JL, Brenner BM.

Circ Res. 1995 Dec;77(6):1240-5.

PMID:
7586237
40.

Fewer nephrons at birth: a missing link in the etiology of essential hypertension?

Mackenzie HS, Brenner BM.

Am J Kidney Dis. 1995 Jul;26(1):91-8. Review.

PMID:
7611275
41.

Effects of chronic treatment with angiotensin converting enzyme inhibitor or an angiotensin receptor antagonist in two-kidney, one-clip hypertensive rats.

Imamura A, Mackenzie HS, Lacy ER, Hutchison FN, Fitzgibbon WR, Ploth DW.

Kidney Int. 1995 May;47(5):1394-402.

42.

Influence of renal mass on chronic kidney allograft rejection in rats.

Heemann UW, Azuma H, Tullius SG, Mackenzie HS, Schmid C, Brenner BM, Tilney NL.

Transplant Proc. 1995 Feb;27(1):549. No abstract available.

PMID:
7879094
43.

Nephron supply is a major determinant of long-term renal allograft outcome in rats.

Mackenzie HS, Tullius SG, Heemann UW, Azuma H, Rennke HG, Brenner BM, Tilney NL.

J Clin Invest. 1994 Nov;94(5):2148-52.

44.

TCV 116 prevents progressive renal injury in rats with extensive renal mass ablation.

Mackenzie HS, Troy JL, Rennke HG, Brenner BM.

J Hypertens Suppl. 1994 Nov;12(9):S11-6.

PMID:
7884578
45.

Renal effects of natriuretic peptide receptor blockade in cirrhotic rats with ascites.

Angeli P, Jiménez W, Arroyo V, Mackenzie HS, Zhang PL, Clària J, Rivera F, Brenner BM, Rodés J.

Hepatology. 1994 Oct;20(4 Pt 1):948-54.

PMID:
7927237
46.

HS-142-1, a potent antagonist of natriuretic peptides in vitro and in vivo.

Zhang PL, Jiménez W, Mackenzie HS, Guo J, Troy JL, Ros J, Angeli P, Arroyo V, Brenner BM.

J Am Soc Nephrol. 1994 Oct;5(4):1099-105.

47.

Evidence for a beneficial effect of increased functional kidney mass upon chronic kidney rejection in rats.

Heemann UW, Tullius SG, Azuma H, Mackenzie HS, Brenner BM, Tilney NL.

Transplant Proc. 1994 Aug;26(4):2047. No abstract available.

PMID:
8066666
48.

Effects of natriuretic peptide receptor inhibition on remnant kidney function in rats.

Zhang PL, Mackenzie HS, Troy JL, Brenner BM.

Kidney Int. 1994 Aug;46(2):414-20.

49.

Effects of an atrial natriuretic peptide receptor antagonist on glomerular hyperfiltration in diabetic rats.

Zhang PL, Mackenzie HS, Troy JL, Brenner BM.

J Am Soc Nephrol. 1994 Feb;4(8):1564-70.

50.

Dye lasers using tapered optical fibers.

Pendock GJ, Mackenzie HS, Payne FP.

Appl Opt. 1993 Sep 20;32(27):5236-42. doi: 10.1364/AO.32.005236.

PMID:
20856331

Supplemental Content

Loading ...
Support Center